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ABSTRACT
Medicinal plants are widely used in traditional medicine in both underdeveloped and 
developing countries in the word until now. Some secondary metabolites isolated from 
medicinal plants have been developed as modern drugs. New antimalarial artemisinin is 
an example of modern medicine that developed from Artemisia annua L, a plant used 
in China since 4,000 years ago.  Indonesia is endowed with a rich natural resource. 
The biodiversity comprises thousands plant species. Therefore, Indonesian flora and 
fauna are a remarkable opportunity for the development of secondary metabolites for 
pharmaceutical industry. The Indonesian National Agency for Drug and Food Control, 
Republic of Indonesia (Badan Pengawas Obat dan Makanan, Republik Indonesia  = BPOM 
RI) classifies traditional medicine into three classes, namely jamu (Indonesian indigenous 
traditional medicine), standardized herbal medicine and phytopharmaca based on its 
scientific evidences. The BPOM also determined 9 medicinal plants for focusing research 
for drug development. This paper discusses  some secondary metabolites and their 
pharmacological activities of the following 9 selected Indonesian medicinal plants namely 
Piper retrofractum Vahl, Andrographis paniculata Ness, Curcuma xanthorrhiza, Psidium 
guajava L, Syzigium polyanthi, Morinda citrifolia, Guazuma ulmifolia Lamk, Zingiber 
officinale, and Curcuma domestica collected from various publications. Furthermore, 
several modern drugs derived from medicinal plants are also discussed.
ABSTRAK
Tanaman obat telah digunakan secara luas dalam pengobatan tradisional baik di negara-
negara belum dan sedang berkembang di dunia hingga saat ini. Beberapa metabolit sekunder 
dari tanaman obat telah dikembangkan menjadi obat modern. Antimalaria artemisinin 
adalah salah satu contoh obat moderen yang dikembangkan dari tanaman Artemisia annua 
L, suatu tanaman obat yang digunakan di Cina sejak 4000 tahun yang lalu. Indonesia 
dianugerahi oleh kekayaan alam yang melimpah dengan ribuan keanekaragaman hayati 
yang terdiri dari ribuan spesies tanaman. Oleh karena itu flora dan fauna Indonesia sangat 
terbuka lebar untuk dikembangkan untuk kepentingan industri farmasi. Badan Pengawas 
Obat dan Makanan, Republik Indonesia (BPOM RI) mengelompokkan obat tradisional 
dalam tiga kelas yaitu jamu, obat herbal terstandar dan fitofarmaka berdasarkan bukti 
ilmiahnya. Ada 9 tanaman Indonesia yang telah ditetapkan oleh BPOM RI untuk menjadi 
fokus penelitian dan pengembangannya menjadi obat. Makalah ini mengulas tentang 
kandungan metabolit sekunder dan aktivitas farmakologi dari ke 9 tanaman obat tersebut 
dari berbagai publikasi yaitu  cabe jawa (Piper retrofractum Vahl), sambiloto (Andrographis 
paniculata Ness), temulawak (Curcuma xanthorrhiza), jambu biji (Psidium guajava L), 
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salam (Syzigium polyantha), mengkudu (Morinda citrifolia), jati belanda (Guazuma ulmifolia 
Lamk), jahe (Zingiber officinale), dan kunyit (Curcuma domestica). Selain itu, beberapa 
obat modern yang telah berhasil dikembangkan dai tanaman obat juga dibahas.
Keywords: medicinal plants - pharmacological activities - pharmaceutical industry 
-secondary metabolite - traditional medicine
INTRODUCTION
Recently, medicinal plants are widely 
used in traditional health care in both 
developing and developed countries. Various 
traditional medicine (TM) from different 
cultures in the word used medicinal plants as 
the backbone for thier health care system.  In 
Indonesia, the use of TM has been embedded 
on the national culture since centuries ago. 
As a mega biodiversity country, Indonesia 
is endowed with a rich natural resource 
including TM materials as a national asset that 
needs to be explored, researched, developed 
and optimized for their utilization. Therefore, 
the national asset has a value and comparative 
advantage as a major base in the capital 
utilization and development efforts to be 
competitive commodity.1
Some attempts have been conducted 
both at the global and regional level for the 
harmonization of standards and quality of 
TM. Therefore, the TM can be traded across 
countries with the same standards and quality. 
World Health Organization (WHO) has 
issued some policies concerning traditional 
medicine, such as WHO Traditional Medicine 
Strategy 2002-2005,2 National Policy on 
Traditional Medicine and Regulation of 
Herbal Medicine,3 and Development of 
Traditional Medicine in the South-East Asia 
Region.4 These policies have been adopted by 
WHO member countries including Indonesia 
in the development their TM potencies. 
As  medicine, the use of TM must meet the 
requirements of safety and effectivenes. The 
TM must be implemented based on scientific 
evidences to improve human health outcomes, 
including physical, mental and social well-
being. Therefore UNESCO’s International 
Bioethics Committee included the subject of 
TM in its work program for 2010-2011.5 
Plant secondary metabolites play an 
important role in determining of biological 
activities of medicinal plants used in TM. 
Therefore, identification and isolation of 
the secondary metabolites are important to 
standardize and to increase quality of the 
TM. Over 24,000 stuctures of secondary 
metabolites have been isolated and evaluated 
its biological activities. Some of them have 
antinutritional and toxic effect on mammals.6 
Moreover, some of plant secondary metabolites 
are successfully developed as modern drugs. 
At least 119 bioactive compounds from plant 
secondary metabolites that were being used as 
drugs. Some of these drugs are still obtained 
commercially, for the most part, by extraction 
from only about 90 species of medicinal 
plants.7 With more than 250 000 species of 
medicinal plants known to exist on this word, 
common sense dictates that many more useful 
drugs remain to be discovered from this 
medicinal plants. 
Some examples of modern drugs developed 
from medicinal plants are new antimalarial 
artemisinin from Artemisia annua L, a plant 
used in China for many centuries,8 inotropic 
digitalis glycosides from Digitalis purpurea,9 
anticancer of vinca alkaloids (vincristine and 
vinblastie, vindesine, and vinorelbine) from 
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Catharanthus roseus10-12, antimuscarinic 
belladonna alkaloids (atropine, hyoscine or 
scopolamine) from Atropa belladonna,13 and 
antirheumatic colchicine commonly produced 
by plants like Colchicum autumnale and 
Gloriosa superb.14 
Indonesia has the biodiversity comprises 
thousands plant species. Therefore, 
Indonesian flora is a remarkable opportunity 
for the development of secondary metabolites 
for pharmaceutical industry. The BPOM 
classifies the TM into three classes, namely 
traditional jamu , standardized herbal 
medicine jamu and phytopharmaca jamu 
based on its scientific evidences. Traditional 
jamu is Indonesian indigenous traditional 
medicine that its use just based on empirical 
experiences. Whereas, standardized herbal 
medicine jamu is dosage form of natural 
medicine which has been proven for its safety 
and pharmacological effect at preclinical 
study, and the material has been standardized 
and phytopharmaca jamu is dosage form of 
natural medicine which  has proven for its 
safety and pharmacologycal effect preclinical 
and clinical study, and its material and product 
have been standardized.15
The BPOM also decided 9 plants to be 
research focus for drug development. These 
plants were investigated their biological 
activities by Indonesian and foreign 
researchers. Furthermore, the secondary 
metabolites of these plants were isolated and 
identified. However, their development both 
as TM or modern drugs remains stagnant. This 
paper discusses  some secondary metabolites 
and their pharmacological activities of the 
9 selected Indonesian medicinal plants that 
potentially developed as TM or modern drugs. 
Several modern drugs derived from medicinal 
plants are also discussed.
DISCUSSION
Indonesian medicinal plants as source of 
secondary metabolites
1. Piper retrofractum Vahl (Cabe Jawa)
Piper retrofractum Vahl (Piperaceae) is 
Indonesian indogenous plant. As  a garden 
medicinal plant, it grows well in secondary 
forests lowland. The synonim of  P. retrofractum 
Vahl  is P. longum. This plant is known locally 
as  cabe jawa, cabe jamu (in Java), cabe solak 
(Madura) and cabia (Sulawesi). Piper longum 
oils contain few secondary metabolites 
monoterpene hydrocarbons, a moderate 
content of sesquiterpenes and high content of 
aliphatic hydrocarbons.16  Piperidine alkaloids 
(FIGURE 1) from P. retrofractum Vahl. 
protect against high-fat diet-induced obesity.17 
FIGURE 1. Piperidine alkaloids isolated from P. retrofractum Vahl
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2. Andrographis paniculata Ness
 (Sambiloto)
Andrographis paniculata Ness is very 
well known in Indonesia as a medicinal plant 
because of its bitter taste. It is known locally 
as sambiloto. Andrographis paniculata 
Ness is traditionally used to treat various 
diseases such as high blood pressure, fever, 
malaria, diabetes, gastrointestinal disorders, 
inflammation, dysentery and cancer. The main 
active compound is andrographolide (FIGURE 
2). However it also contains flavonoids such as 
5,7,2’, 3’-tetrametoksiflavanon, 5-hydroxy-7, 
2’, 3’-trimetoksiflavon,18 5-hydroxy-7’, 
2’,6-trimetoksiflavon and 14-deoxy-15,12-
11-isopropiliden-dehidroandrografolid.19 
Andrographolide has been proven to have a 
variety of pharmacological activities such as 
anti-inflammatory, antibacterial, antidiabetic, 
and anticancer. Shi et al.19 reported that 
andrographolide inhibits invasion and migration 
of colorectal cancer cells by inhibiting the 
activity of MMP-7 expression, whereas Lee et 
al.20 proved andrographolide inhibits invasion 
and migration of lung cancer cells (A-549) 
by inhibiting P13K/Akt signaling pathways. 
Some andrographolide derivatives have been 
successfully synthesized and tested for their 
anticancer activity by several researchers. Jada 
et al.21 reported that benzylidene derivatives 
of andrographolide inhibit growth of breast 
and colon cancer cells in vitro by inducing 
G(1) arrest and apoptosis. 
FIGURE 2.  Andrographolide isolated from A. panicu-
lata Ness
3. Curcuma xanthorrhiza (Temu Lawak)
Curcuma xanthorriza has been used 
traditionally by Indonesian people to cure 
acne, increased appetite, anti-cholesterol, anti-
inflammatory, anemia, antioxidant, cancer 
prevention, and antimicrobial. It is well known 
as  temu lawak. Curcuma xanthorriza has a 
variety of pharmacological activities such as 
analgesic, antidiabetic, antihyperlipidemic 
and stimulants. Beside curcumin, some 
other specific active compound found in C. 
xanthorriza, i.e. xanthorrizol, ar-tumerone 
and α-curcumin (FIGURE 3). Xanthorrizol as 
the main compound in C. xanthorriza has been 
proven as  antioxidant and anti-inflammatory.22 
Activity and cytotoxic mechanism of 
xanthorrizol in some cancer cells in vitro 
have been reported by several investigators. 
Ismail et al.23 reported xanthorrizol induce 
apoptosis of HeLa cells via the up-regulation 
of bax and p53. Xanthorrizol also showed 
antiproliferative activity in breast cancer 
cells  MCF-7 via apoptosis induction through 
modulation of bcl-2, p53 protein and PARP-
1.24
FIGURE 3. Some active compounds isolated from C. 
xanthorriza.
Another study conducted by Handayani 
et al.25 proved that xanthorrizol has 
antiproliferative activity on hepatoma HepG2 
cell by inducing apoptosis through p53, Bcl-
2 and caspase-dependent signaling pathway. 
Xanthorrizol also reported to inhibit the 
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proliferation of HCT116 colon cancer cells 
line by inhibiting the cell cycle in the G0/G1 
phase and G2/M regulation through inhibition 
of cyclin A, B1, and D1 and cyclin-dependent 
kinase 1 (CDK1), CDK2 and CDK4. It also 
has p21, p27 and cyclin-dependent kinase 
inhibitors activity.26
4. Psidium guajava L (Jambu Biji)
Psidium guajava, commonly known as 
guava or jambu biji in Indonesia is belonging 
to family of Myrtaceae, native plant of tropical 
America and has long spread to southeast Asia. 
Guava is a fruit rich in bioactive compounds 
that may be used in various way to offer to  the 
population the possibility of preventing certain 
chronic disease at low cost because of its 
antioxidant activity.27 Guava leaf extracts are 
rich sources of natural antioxidants and could 
be developed into functional food or drug 
against diseases and for a variety of beneficial 
chemo-preventive effects.28 Guava extract 
exerted a potent anti-nociceptive effect.29 
Begum et al.30 reported that two triterpenoids, 
20b-acetoxy-2a,3b-dihydroxyurs-12-en-
28-oic acid (guavanoic acid) and 2a,3b-
dihydroxy-24-p-z-coumaroyloxyurs-12-en-
28-oic acid (guavacoumaric acid) along with 
FIGURE 4. Asiatic acid isolated from P. guajava
5. Syzigium polyanthi (Salam)
Syzigium polyanthi with its synonym 
Eugenia polyantha or Indonesian bay leaf is 
one of spice used in Indonesia. It is known as 
salam in Java.  It has antioxidant activity.31 
Three phenolic pancreatic lipase inhibitors 
(FIGURE 5) were isolated from E. polyanthi. 
Although the activities of the isolated 
compounds were mild, the abundant content 
of hydroxychavicol  in this spice makes it quite 
attractive as a food additive for the treatment 
and prevention of obesity.32
FIGURE 5.  Three phenolic pancreatic lipase inhibitors isolated from E. polyanthi.
2a-hydroxyursolic acid,  jacoumaric acid, 
isoneriucoumaric acid, asiatic acid,  ilelatifol 
D, and b-sitosterol-3-O-b-d-glucopyranoside 
have been isolated from P. guajava leaves. The 
asiatic acid (FIGURE 4) showed spasmolytic 
activity.30
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6. Morinda citrifolia (Mengkudu)
Morinda citrifolia  has been used in 
traditional Polynesian medicine for over 2000 
years. Its Indonesian name is mengkudu. It is 
reported to have a broad range of therapeutic 
effects, including antibacterial, antiviral, 
antifungal, antitumor, antihelmint, analgesic, 
hypotensive, anti-inflammatory, and immune 
enhancing effects.33 Morinda citrifolia is an 
evergreen shrub whose ripe fruit has a strong 
butyric acid smell and flavor. The leaves and 
especially the fruit are consumed in different 
forms by various communities throughout the 
world, the root is used as a dye.34 Morinda 
citrifolia aquous extract as well as its biomarker 
scopoletin  (FIGURE 6) may be beneficial as 
a potential preventive and therapeutic agent 
for gastro-esophageal inflammatory diseases, 
mainly through its antisecretory and prokinetic 
activities including an inhibitory activity 
on serotonin, free radicals, and cytokine-
mediated inflammation.35,36  A known major 
component (scopoletin) in M. citrifolia was 
chosen as a marker and monitored in the 
plasma and in different organs over time 
by HPLC analysis.33 Other contents are 
alizarin, aucubin, aracetin, asperulocidic 
acid, citrifolinoside B, damnacanthal, 
1,3-dihydroxy-6-methyl anthraquinone, 
5,6-dihydroxylucidin, 2-methyl-4-
hydroxy-5,7-dimethoxyanthraquinone, 
3-hydroxymorindone, 8-hydroxy-8-methoxy-
2-methyl-anthraquinone, lucidin, 2-methyl-
3,5,6-trihydroxyanthraquinone, morenone 
FIGURE 6.  Scopoletin isolated from M. citrifolia
7. Guazuma ulmifolia Lamk (Jati Belanda)
In traditional medicine, the bark of 
G. ulmifolia Lamk, with local name jati 
belanda, is used in the treatment of diarrhea, 
hemorrhages, fever, inflammatory diseases, 
and as stimulant for uterine contractions. 
Dried leaves are brewed into tea in some 
countries and used for gastrointestinal 
diseases and dysentery. The aerial parts of G. 
ulmifolia Lamk have shown a gastroprotective 
effect against the injurious effect of NSAIDs 
(non-steroidal anti-inflammatory drugs) 
mainly by anti-inflammatory and radical-
scavenging mechanisms.37 Fraction obtained 
from G. ulmifolia Lamk bark produces 
significant antihypertensive effects. The 
phenolic compounds such as oligomeric 
procyanidins were detected in the PCF 
by FAB+-MS and HPLC–DAD–ESI/
MS analysis.38 The chemical structure of 
polymeric proanthocyanidin and oligomeric 
proanthocyanidin were shown in FIGURE 7.39 
1, morenone 2, morindanidrine, morindine, 
morindone, physcion, ruberythric acid, 
rubiadin, rubiadin monomethyl ether, 
soranjidiol, and ursolic acid.34
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FIGURE 7.  Oligomeric proanthocyanidin and polymeric proanthocyanidin isolated from G. ulmifolia
8.	 Zingiber	officinale	(Jahe)
Zingiber officinale or called jahe in Java, is 
known as seasoning. Traditionally, it also used 
as a carminative and stimulant, to increase 
appetite, treat the digestive tract disorder such 
as nausea and vomit, to treat common cold, 
cough, diarrhea, malaria, fever and arthritis. 
Some scientific research have proven that  it 
has some pharmacological activity such as 
immunomodulator and antimicrobial,40 in vitro 
antihelminth,41  antinausea and vomiting,42 
antioxidant,43 and anticancer.44
Phytochemical studies of Z. officinale showed 
that it contains some chemical compounds from 
various groups such as paradol, dihydroparadol, 
gingerol, acetyl gingerol derivatives, shogaol, 
3-dihydroshogaol, gingerdiol, mono-and diacetyl 
gingerdiol derivatives, 1-dehydrogingerdione, 
diarylheptanoide and metal ether derivatives.45 
The chemical structure of some active compound 
of  Z. officinale can be seen in FIGURE 8. 
Among some active compounds, gingerol is 
compound which is often used by researchers 
as a marker for extract standardization.
FIGURE 8.  Some active isolated from Z. officinale.
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9. Curcuma domestica (Kunyit)
Curcuma domestica with its synonim 
C. longa is one of the ginger family, 
Zingiberaceae that widely distributed in 
Asia.46,47 Curcuma domestica has been used 
as seasoning, food coloring and traditional 
medicine. In Indonesia it is well known as 
jahe. As a traditional medicine, C. domestica 
has been used to treat various diseases such as 
diabetes, leprosy, gastrointestinal disorders, 
tonic, laxative, rheumatic, antiseptic, hepatic 
disorders, and cancer. Curcuma domestica 
contains curcumin and its derivatives such as 
bis-demetoxycurcumin, demetoxycurcumin. 
It contains active compounds such as 
curcumarol, α-, β-and ar-turmerone, and 
zingiberene (FIGURE 9).
FIGURE 9. Some active compounds of Curcuma domestica
Curcumin and its derivatives have been 
widely demonstrated to have great potential 
to be developed as anticancer. From several 
studies summarized by Aggrawal et al.48 
showed that curcumin can inhibit the in 
vitro proliferation of various cancer cells 
such as T and B cell leukemia, colon cancer, 
skin cancer, breast cancer BT20, SKBR3, 
MCF7, T47D and ZR75-1. Various in vivo 
studies in experimental animal also showed 
that curcumin has chemopreventive and 
chemotherapeutic activities in animal models 
of cancer. Curcumin has been shown to 
inhibit tumor initiation induced by benzo(a)
pirene and 7,12dimetilbenz (a) antrasen in 
mice. Curcumin is reported to suppress mouse 
skin tumor induced by forbol ester, suppress 
carcinogenesis in skin cancer, stomach, colon, 
liver and breast cancer in mice.49
Modern drugs developed from medicinal 
plants
1. Artemisinin
Artemisinin was isolated from Artemisia 
annua L, a plant used in China for many 
centuries. Artemisinin is a sesquiterpene 
lactone that bears a peroxide grouping 
and, unlike most other antimalarials, lacks 
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a nitrogen-containing heterocyclic ring 
system.8 Subsequent studies of the structure 
activity relationship led to the discovery 
of dihydroartemisinin, artemether and 
artesunate. Artemisinin and these three 
derivatives (FIGURE 10) are being used 
around the world as effective new antimalarial 
drugs against falciparum malaria, including 
multi-drug-resistant Plasmodium falciparum. 
At the present time new artemisinin analogues 
or derivatives are being developed. In 
addition, recent studies also indicate that 
some artemisinin derivatives have other 
biological activities including antiparasitic 
and anticancer activities.50
FIGURE 10. Artemisinin and its derivatives
2. Digitalis glycosides
Digoxin and digitoxin (FIGURE 11) 
known as cardiac glycosides is one example 
of a modern drug glycoside isolated from 
the plant digitalis (Digitalis purpurea).9,51 
Digoxin and digitoxin are cardiac glycoside 
with positive inotropic activity. They increase 
force and velocity of myocardial systolic 
contraction (positive inotropic action), slow 
heart rate, decrease conduction velocity 
through AV node, and decrease the degree of 
activation of the sympathetic nervous system 
and renin-angiotensin system.52 
FIGURE 11.  Digoxin and digitoxin
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3. Vincristine and vinbalastine
Some anticancer used in cancer therapy 
firstly isolated from medicinal plants.  Vinca 
alkaloids (vincristine and vinblastie) were 
isolated from Catharanthus roseus.10-12 
Vinblastine and vincristine (FIGURE 12) 
are alkaloids which used for treatment of 
leukemias, lymphomas, and testicular cancer. 
A closely related derivative, vinorelbine, has 
important activity against lung cancer and 
breast cancer.52
FIGURE 12. Vinblastine (R=CH3) and vincristine 
   (R=CHO).
4. Atropine and hyoscine (scopolamine)
Atropine is major alkaloids of Atropa 
belladonna. Further alkaloids in the leaves 
are apoatropine, tropine, scopolamine, 
aposcopolamine, 3-α-phenyl-acetoxytropane, 
and tropinone.13 Atropine (FIGURE 13) 
inhibits action of acetylcholine or other 
cholinergic stimuli at postganglionic 
cholinergic receptors, including smooth 
muscles, secretory glands, and central nervous 
system (CNS) sites. Hyoscine (scopolamine) 
(FIGURE 13) competitively inhibits action 
of acetylcholine at muscarinic receptors. 
Principal effects are on iris and ciliary body 
(pupil dilations and blurred vision), secretory 
glands (dry mouth), drowsiness, euphoria, 
fatigue, decreased nausea, and vomiting. 
Atropine and scopolamine differ quantitatively 
in antimuscarinic actions, particularly in their 
ability to affect the CNS. Atropine has almost 
no detectable effect on the CNS at doses that 
are used clinically. In contrast, scopolamine 
has prominent central effects at low therapeutic 
doses. Because atropine has limited CNS 
effects, it is preferred to scopolamine for most 
purposes.52
FIGURE 13.  Atropine and hyoscine (scopolamine)
5. Colchicine
Colchicine is also known as methyl ether 
of colchicines. It is secondary metabolite 
commonly produced by plants like Colchicum 
autumnale and Gloriosa superba, It is 
originally used to treat rheumatic complaints, 
especially gout.14  Colchicine is one of the 
oldest available therapies for acute gout. It is 
considered second-line therapy due to a narrow 
therapeutic window and a high rate of side 
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effects, particularly at higher doses. The exact 
mechanism of action of colchicine in gout is 
not completely known. However, it involves 
in a reduction of lactic acid production by 
leukocytes leads to a decrease in uric acid 
deposition, and a reduction in phagocytosis, 
with abatement of the inflammatory response.52
FIGURE 14.  Colchicine
CONCLUSION
Many secondary metabolites have been 
isolated from Indonesian medicinal plants. 
Some of them have potential biological activities 
to further development for pharmaceutical 
industry both as TM or modern drugs. To 
develop the Indonesian medicinal plant as 
national product that can be competitive in 
multinational market,  studies these plants 
for its safety, efficacy and standardization are 
necessary. Working collaboration between 
botanists, phytochemists, pharmacologists, 
organic chemists and others are important to 
pursue goal targeted.
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